抗体
试剂盒
多肽
蛋白
组织芯片
产品中心
Product Center
Research Grade Rinucumab
All
TD-HY260016_1.jpg
- Catalog： TD-HY260016
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： REGN-2176,REGN-2176-3(combinationofafliberceptandricunumab),REGN2176,CAS:1569263-06-4
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Rinucumab
| Catalog No. | TD-HY260016 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Human |
| Isotype | IgG4-kappa |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | Beta-type platelet-derived growth factor receptor, Beta platelet-derived growth factor receptor, CD140b, Platelet-derived growth factor receptor 1, PDGFRB, PDGF-R-beta, Platelet-derived growth factor receptor beta, CD140 antigen-like family member B, PDGFR-1, PDGFR1, PDGFR-beta, PDGFR |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G, purified from cell culture supernatant. |
| Accession | P09619 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | REGN-2176,REGN-2176-3(combinationofafliberceptandricunumab),REGN2176,CAS:1569263-06-4 |
| Background | Rinucumab (REGN 2176), a monoclonal antibody, is a PDGF inhibitor. Rinucumab (REGN 2176) could be used for the study of neovascular age-related macular degeneration. |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|
|
SDS-PAGE for Research Grade Rinucumab. |